Management believes that information management capability is crucial for providing data and information to users with appropriate levels of accuracy, timeliness, reliability, security, confidentiality, connectivity, and access, and for tailoring these in response to changing business needs and directions. The firm’s IT capabilities represent the application of physical or intangible IT resources such as technology, knowledge, practices, relationships, management skills, business process understanding, and human resources to further organizational goals. The integration of certain manufacturing assets and biologic tissue capabilities into the structural heart business is expected to enhance operational efficiency and support business innovation. The company is committed to advancing medical technologies and investing in meaningful research and development projects across its businesses, which will contribute to profitable sales growth. The firm’s strategic imperatives to drive global expansion include seeking to grow net sales and market share by expanding its global presence, particularly in emerging markets, which are defined as countries with strong growth potential based on economic conditions and healthcare sectors. The company’s investment in infrastructure in these countries is aimed at maximizing opportunities and enhancing its market responsiveness. The management's assessment of internal control over financial reporting indicates that it is effective, which is essential for ensuring the reliability of financial reporting and the preparation of financial statements in accordance with generally accepted accounting principles. The company’s restructuring initiatives are designed to reduce gross annual expenses and are expected to result in significant savings that will be reinvested in strategic growth initiatives. The firm’s ability to mobilize and deploy IT-based resources in combination with other resources and capabilities underscores its competitive advantage in transforming into a competitive force. The firm’s cash generated from operations continues to be a significant source of funds for investing in growth, including acquisitions and strategic alliances, which are essential for maintaining its market position. The company’s strategic resource allocation is focused on enhancing its operational flexibility and market agility, which are critical for responding to market dynamics and consumer demands. The firm’s commitment to process optimization and technology integration is reflected in its ongoing efforts to enhance its product offerings and improve customer relationships. The management emphasizes the importance of leveraging IT capabilities to support business needs and enhance organizational performance, which is vital for sustaining competitive positioning in the market. The company’s focus on innovation partnerships and strategic management practices aims to facilitate process development and enhance its technology portfolio, thereby supporting its long-term growth objectives.